|
PVRL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.520800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.624200E-01 |
| Normal-vs-Stage2 |
8.837200E-01 |
| Normal-vs-Stage3 |
6.913000E-01 |
| Normal-vs-Stage4 |
4.903000E-01 |
| Stage1-vs-Stage2 |
9.686400E-01 |
| Stage1-vs-Stage3 |
7.812200E-01 |
| Stage1-vs-Stage4 |
4.139400E-01 |
| Stage2-vs-Stage3 |
8.538800E-01 |
| Stage2-vs-Stage4 |
4.382000E-01 |
| Stage3-vs-Stage4 |
3.699400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.761800E-01 |
| Normal-vs-AfricanAmerican |
7.606200E-01 |
| Normal-vs-Asian |
5.064200E-01 |
| Caucasian-vs-AfricanAmerican |
2.297200E-01 |
| Caucasian-vs-Asian |
5.850400E-01 |
| AfricanAmerican-vs-Asian |
7.872400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.391200E-01 |
| Normal-vs-Female |
1.132420E-02 |
| Male-vs-Female |
6.423100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.956000E-01 |
| Normal-vs-Extreme_Weight |
9.231200E-01 |
| Normal-vs-Obese |
3.439400E-01 |
| Normal-vs-Extreme_Obese |
7.357800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.425800E-01 |
| Normal_Weight-vs-Obese |
1.875400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.628600E-01 |
| Extreme_Weight-vs-Obese |
4.993000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.687400E-01 |
| Obese-vs-Extreme_Obese |
4.550800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.629800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.049800E-02 |
| Normal-vs-Age(61-80Yrs) |
6.193400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.260390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.556800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.541390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.710000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.077900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.064300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.746800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.545800E-01 |
| Normal-VS-Type2 PRCC |
2.185000E-01 |
| Normal-VS-KIRP CIMP |
1.561610E-01 |
| Normal-VS-Unclassified PRCC |
9.686100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.000000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.869600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.531360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.924300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.802400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.793000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.522390E-01 |
| Normal-vs-N1 |
2.217000E-01 |
| Normal-vs-N2 |
8.216800E-01 |
| N0-vs-N1 |
6.284200E-02 |
| N0-vs-N2 |
6.884400E-01 |
| N1-vs-N2 |
9.161200E-01 |
|
|
